DEK was originally identified in acute myeloid leukemia as a fusion protein with NUP214 [1], and was subsequently shown to be overexpressed at the mRNA and protein levels in various cancer types including squamous cell carcinoma (SCC) [2–7]. This evidence concerns the gene DEK and cancer.